Are you on the hunt for the best NMN supplement? If you’ve been keeping up with the latest scientific evidence, you should be. This powerhouse ingredient has a plethora of reported benefits.

This is where Nicotinamide Mononucleotide (NMN) supplements step into the spotlight. NMN supplements are widely recognized for supporting brain health and are increasingly regarded as a beacon of ...

The United States's dominance in biotech innovation is crucial to our national interests and global security. In recent years, China has quickly become a powerhouse, bolstered by its biotech ...

Cell therapy biotech Tolerance Bio has unveiled with $17.2 million and a mission of targeting immune diseases by stretching and saving the function of a key organ. The Philadelphia biotech’s ...

These longtime leading biotech stocks still have plenty of upside ahead. October typically isn't a time investors look forward to in the markets. It has historically been associated with equities ...

French biotech startup Generare has closed a €5 million seed round (around $5.5 million at current exchange rates) to step up development of what it touts as a highly scalable approach to ...

Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world. Millions of people have used its simple genetic testing service ...

Taking the mat is Judo Bio, an up-and-coming biotech armed with $100 million to develop oligonucleotide medicines targeting the kidney. Instructing Judo is CEO Rajiv Patni, M.D., an industry vet ...

Apr. 23, 2024 — Researchers describe the steps they took to manipulate DNA and proteins -- essential building blocks of life -- to create cells that look and act like cells from the body. This ...

Even during this tense election year, bipartisan coalitions are taking steps to enhance national security, protect American-owned intellectual property and secure the country’s supply chain by ...

US Venture Capital Opens Path to Funding for China Biotech Firms Five US startups funded in 2024 to develop drugs from China Trend shows potential of China-originated assets, says analyst ...